Sildenafil Tablet, Film Coated
Product Images NDC 72241-070

Product Visual Gallery

This gallery contains 19 technical images submitted to the FDA as part of the official labeling for Sildenafil (NDC 72241-070). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Modavar Pharmaceuticals Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Fig-1 (Fig 1)

FDA Label Image

Fig-2 (Fig 2)

This text provides data on the change in systolic blood pressure (SBP) in mmHg over time postdose for two different treatments: Doxazosin + Placebo and Doxazosin + Sildenafil 25 mg. The values for SBP are shown at hours 5, 6, and 7 postdose.*

FDA Label Image

Fig-3 (Fig 3)

This text provides information about the change in systolic blood pressure (SBP) in mmHg for different treatment groups over time postdose (in hours). The groups mentioned are Doxazosin + Placebo and Doxazosin + Sildenafil 50 mg, with corresponding values of change in SBP shown.*

FDA Label Image

Fig-4 (Fig 4)

This text provides information on blood pressure (mmHg) readings at different time intervals after taking different medication combinations: Doxazosin + Sildenafil 100 mg, Doxazosin + Placebo. It appears to be a chart or table showing the effects of these treatments on blood pressure over time.*

FDA Label Image

Fig-5 (Fig 5)

FDA Label Image

Fig-6-1 (Fig 6 1)

This text provides data on the percentage of patients at the endpoint based on different scores. The scores range from 1 to 8, with various percentages of patients falling into each score category. It also mentions a baseline score.*

FDA Label Image

Fig-6-2 (Fig 6 2)

FDA Label Image

Fig-7 (Fig 7)

FDA Label Image

Modavar-cont-label-1000mg-100-tab.jpg (Modavar Cont Label 1000mg 100 Tab)

This is the description: Sildenafil Tablets, USP in 1000 tablet packaging. Contains: 72241-071-11. Manufacturer: Noc. Item code: 0272024. Dosage strength 20mg. For oral use.*

FDA Label Image

Modavar-cont-label-100mg-100-tab.jpg (Modavar Cont Label 100mg 100 Tab)

FDA Label Image

Modavar-cont-label-100mg-30-tab.jpg (Modavar Cont Label 100mg 30 Tab)

FDA Label Image

Modavar-cont-label-25mg-100-tab.jpg (Modavar Cont Label 25mg 100 Tab)

This text is a label for sildenafil tablets, USP (dosage strength not clearly mentioned) with safety instructions and manufacturing information. It includes warnings to keep the medication out of reach of children and indicates the manufacturer as Modavor Catala Pharmaceuticals Ltd in India. The label also states that each tablet contains sildenafil equivalent to 125 mg.*

FDA Label Image

Modavar-cont-label-25mg-1000-tab.jpg (Modavar Cont Label 25mg 1000 Tab)

Not available.*

FDA Label Image

Modavar-cont-label-25mg-30-tab.jpg (Modavar Cont Label 25mg 30 Tab)

FDA Label Image

Modavar-cont-label-50mg-100-tab.jpg (Modavar Cont Label 50mg 100 Tab)

NDC 72241-070-05 Sildenafil Tablets, USP by Modavar. This prescription medication comes in a pack of 100 tablets, each containing 50 mg of the active ingredient. Dosage instructions should be carefully followed to ensure effectiveness. Keep this product out of reach of children. Manufactured by Cadila Pharmaceuticals Ltd.*

FDA Label Image

Modavar-cont-label-50mg-1000-tab.jpg (Modavar Cont Label 50mg 1000 Tab)

FDA Label Image

Modavar-cont-label-50mg-30-tab.jpg (Modavar Cont Label 50mg 30 Tab)

This is a description of Sildenafil tablets with dosages equivalent to 50mg and 100mg. The medication is manufactured in India by Modavar Pharmaceuticals LLC and distributed in the US. It is important to keep this and all medications out of reach of children. The package contains 30 tablets and is for prescription use only.*

FDA Label Image

Structure (Structure)

FDA Label Image

Hemodynamic (Table 3)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.